Wednesday, June 10, 2026

Patent intelligence · CN

CN 118401500

Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes

granted
Status granted
Years to expiry 18
Applicant portfolio 25
Patent details — CN 118401500

Quick answer

CN 118401500 (Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes) is held by BRACCO IMAGING SPA. Status: granted. Granted Jul 26, 2024. Expires Jul 21, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
BRACCO IMAGING SPA
Grant date
Expiration
Claims

More from BRACCO IMAGING SPA

Related pharmaceutical patents in our USPTO index.

  1. CN 119365549

    Fluorescent probe targeting CA-IX

    BRACCO IMAGING SPA · Expires Jan 19, 2045

    granted
  2. CN 119343336

    1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents

    BRACCO IMAGING SPA · Expires Jan 16, 2045

    granted
  3. CN 119325492

    Fluorescent probe targeting CA-IX

    BRACCO IMAGING SPA · Expires Jan 12, 2045

    granted
  4. US 2024131199

    PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Expires Apr 20, 2044

    granted
  5. KR 20240034693

    이량체 조영제의 제조

    BRACCO IMAGING SPA [IT] · Expires Mar 9, 2044

    granted
  6. US 2023312523

    NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Expires Sep 30, 2043

    granted
  7. KR 20230116805

    가도테리돌 제조를 위한 제조 방법

    BRACCO IMAGING SPA [IT] · Expires Jul 30, 2043

    granted

Frequently asked questions

What is US patent 118401500?

CN 118401500 (Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes) is held by BRACCO IMAGING SPA. Status: granted. Granted Jul 26, 2024. Expires Jul 21, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Who owns CN 118401500?

BRACCO IMAGING SPA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does CN 118401500 expire?

Our index shows an expiration date of Jul 21, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.